New cancer drug enters human testing for Tough-to-Treat tumors
NCT ID NCT06555744
Summary
This is a first-in-human study to test the safety and early signs of effectiveness of a new cancer drug called ZW191. It is for adults with advanced solid tumors, such as ovarian, endometrial, and non-small cell lung cancers, that have spread or returned. The main goal is to find a safe dose and see how the body handles the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
Contact
-
Curie Oncology
RECRUITINGSingapore, 217562, Singapore
Contact
-
Fundacion Instituto Valenciano de Oncologia (IVO)
RECRUITINGValencia, 46009, Spain
Contact
-
Gangnam Severance Hospital
RECRUITINGSeoul, 6273, South Korea
Contact
-
Hospital Clinico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
Contact
-
Hospital Universitario Reina Sofia
RECRUITINGCórdoba, 14004, Spain
Contact
-
Linear Clinical Research
RECRUITINGNedlands, WA 6009, Australia
Contact
-
NEXT Oncology
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
Contact
-
National Cancer Center
RECRUITINGGoyang-si, 10408, South Korea
Contact
-
National Cancer Center Hospital
RECRUITINGTokyo, 104-0045, Japan
Contact
-
National Cancer Center Hospital East
RECRUITINGKashiwa-shi, 277-8577, Japan
Contact
-
National Cancer Centre Singapore
RECRUITINGSingapore, 168583, Singapore
Contact
-
National University Health System (NUHS) - National University Cancer Institute Singapore (NCIS)
RECRUITINGSingapore, 119228, Singapore
Contact
-
Royal North Shore Hospital Northern Sydney Cancer Centre
RECRUITINGSt Leonards, NSW 2065, Australia
Contact
-
Saitama Medical University International Medical Center
RECRUITINGSaitama, 350-1298, Japan
Contact
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
Contact
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, 13620, South Korea
Contact
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
Contact
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
Contact
-
Stephenson Cancer Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact
-
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
RECRUITINGColumbus, Ohio, 43210, United States
Contact
-
The Cancer Institute Hospital of JFCR
RECRUITINGTokyo, 135-8550, Japan
Contact
-
Yale University
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
Conditions
Explore the condition pages connected to this study.